Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for HRMY

Stock Name	Harmony Biosciences Holdings
Ticker	HRMY(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US4131971040

Show aggregate HRMY holdings

News associated with HRMY

Harmony Biosciences Holdings Breaks Below 200-Day Moving Average - Notable for HRMY: In trading on Tuesday, shares of Harmony Biosciences Holdings Inc (Symbol: HRMY) crossed below their 200 day moving average of $34.34, changing hands as low as $33.45 per share. Harmony Biosciences Holdings Inc shares are currently trading off about 6.4% on the day. The chart - 2025-09-09 12:41:14
Validea Joel Greenblatt Strategy Daily Upgrade Report - 9/5/2025: The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.HARMONY BIOSCIENCES HOLDINGS INC (HRMY) is a mid-cap value stock - 2025-09-05 06:14:36
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Sold by Maryland State Retirement & Pension System: Maryland State Retirement & Pension System lowered its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 13.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 11,165 shares of the company’s stock after selling 1,693 shares during the period. Maryland […] - 2025-08-17 05:17:01
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $51.00 Average Price Target from Brokerages: Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has earned an average recommendation of “Buy” from the ten ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and one has given a strong buy recommendation to […] - 2025-08-13 03:14:50
Harmony Biosciences (NASDAQ:HRMY) Rating Lowered to Hold at Wall Street Zen: Wall Street Zen cut shares of Harmony Biosciences (NASDAQ:HRMY – Free Report) from a buy rating to a hold rating in a research note issued to investors on Saturday morning. Several other research analysts have also issued reports on HRMY. Needham & Company LLC reiterated a “buy” rating and issued a $49.00 price target on […] - 2025-08-12 04:34:55
Validea Joel Greenblatt Strategy Daily Upgrade Report - 8/7/2025: The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.GRIFFON CORP (GFF) is a mid-cap value stock in the Appliance &am - 2025-08-07 06:54:43
Arizona State Retirement System Purchases 737 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Arizona State Retirement System grew its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 6.4% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,261 shares of the company’s stock after buying an additional 737 […] - 2025-07-23 05:44:46
Bank of New York Mellon Corp Has $8.70 Million Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Bank of New York Mellon Corp lowered its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 1.3% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 262,238 shares of the company’s stock after selling 3,401 shares during the quarter. Bank of New York Mellon Corp’s holdings in Harmony Biosciences were worth […] - 2025-07-22 06:49:00
Truist Financial Begins Coverage on Harmony Biosciences (NASDAQ:HRMY): Research analysts at Truist Financial initiated coverage on shares of Harmony Biosciences (NASDAQ:HRMY – Get Free Report) in a report released on Monday, MarketBeat.com reports. The brokerage set a “buy” rating and a $48.00 price target on the stock. Truist Financial’s price target would indicate a potential upside of 36.17% from the company’s current price. […] - 2025-07-22 04:58:48
Louisiana State Employees Retirement System Sells 500 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Louisiana State Employees Retirement System trimmed its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 2.7% in the first quarter, Holdings Channel reports. The firm owned 18,000 shares of the company’s stock after selling 500 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Harmony Biosciences were worth $597,000 as […] - 2025-07-21 05:16:49
Principal Financial Group Inc. Buys 4,753 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Principal Financial Group Inc. lifted its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 2.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 213,416 shares of the company’s stock after purchasing an additional 4,753 shares during the […] - 2025-07-16 04:38:44
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives $53.63 Consensus PT from Brokerages: Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has received a consensus rating of “Buy” from the eight research firms that are covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month target price […] - 2025-06-24 02:36:53
Exchange Traded Concepts LLC Takes Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Exchange Traded Concepts LLC acquired a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 30,256 shares of the company’s stock, valued at approximately $1,004,000. Exchange Traded Concepts LLC owned 0.05% of Harmony […] - 2025-06-20 05:16:57
Validea Joel Greenblatt Strategy Daily Upgrade Report - 6/13/2025: The following are today's upgrades for Validea's Earnings Yield Investor model based on the published strategy of Joel Greenblatt. This value model looks for companies with high return on capital and earnings yields.CUREVAC BV (CVAC) is a small-cap value stock in the Biotechnolog - 2025-06-13 06:35:45
Harmony Biosciences Holdings (HRMY) Shares Cross Below 200 DMA: In trading on Thursday, shares of Harmony Biosciences Holdings Inc (Symbol: HRMY) crossed below their 200 day moving average of $34.67, changing hands as low as $34.50 per share. Harmony Biosciences Holdings Inc shares are currently trading down about 1.6% on the day. The char - 2025-06-05 12:53:08
Squarepoint Ops LLC Has $582,000 Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Squarepoint Ops LLC boosted its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 125.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 16,901 shares of the company’s stock after purchasing an additional 9,411 shares during the period. Squarepoint Ops LLC’s holdings in Harmony Biosciences […] - 2025-06-04 05:06:50
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.24 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 94,011 shares of the company’s stock, valued at approximately $3,235,000. Universal Beteiligungs und Servicegesellschaft mbH owned […] - 2025-06-03 05:10:48
Nuveen Asset Management LLC Has $7.31 Million Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Nuveen Asset Management LLC lifted its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 4.0% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 212,351 shares of the company’s stock after buying an additional 8,193 shares during the quarter. Nuveen Asset Management LLC’s holdings in Harmony Biosciences were worth […] - 2025-05-30 05:00:50
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Two Sigma Advisers LP: Two Sigma Advisers LP grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 21.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 98,900 shares of the company’s stock after buying an additional 17,700 shares during the quarter. Two […] - 2025-05-27 06:37:02
ProShare Advisors LLC Increases Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): ProShare Advisors LLC grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 47.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,190 shares of the company’s stock after purchasing an additional 4,534 shares during the period. […] - 2025-05-27 06:00:51
Bank of America Corp DE Lowers Stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Bank of America Corp DE lessened its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 35.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 202,508 shares of the company’s stock after selling 113,458 shares during the quarter. Bank […] - 2025-05-27 05:16:49
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Rating of “Buy” by Analysts: Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) have been given an average rating of “Buy” by the nine brokerages that are currently covering the company, Marketbeat reports. Eight research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average […] - 2025-05-27 02:48:52
Comerica Bank Has $464,000 Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Comerica Bank grew its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 27.6% in the fourth quarter, HoldingsChannel reports. The fund owned 13,495 shares of the company’s stock after acquiring an additional 2,919 shares during the period. Comerica Bank’s holdings in Harmony Biosciences were worth $464,000 as of its most […] - 2025-05-16 05:20:57
Needham & Company LLC Reaffirms Buy Rating for Harmony Biosciences (NASDAQ:HRMY): Harmony Biosciences (NASDAQ:HRMY – Get Free Report)‘s stock had its “buy” rating reissued by research analysts at Needham & Company LLC in a report issued on Tuesday,Benzinga reports. They presently have a $49.00 target price on the stock. Needham & Company LLC’s price target suggests a potential upside of 46.44% from the stock’s previous close. […] - 2025-05-08 04:40:44
Harmony Biosciences (NASDAQ:HRMY) Shares Gap Up Following Better-Than-Expected Earnings: Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report)’s share price gapped up before the market opened on Tuesday following a stronger than expected earnings report. The stock had previously closed at $29.96, but opened at $31.11. Harmony Biosciences shares last traded at $31.61, with a volume of 147,182 shares changing hands. The company reported […] - 2025-05-08 02:25:26
How The Pieces Add Up: IJR Headed For $129: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-05 08:51:52
Analysts Set Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Target Price at $52.44: Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) has earned a consensus recommendation of “Buy” from the nine analysts that are presently covering the company, Marketbeat.com reports. Nine investment analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have updated their coverage on the stock in […] - 2025-05-05 02:49:06
Barclays PLC Increases Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Barclays PLC grew its position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 31.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 100,872 shares of the company’s stock after purchasing an additional 24,010 shares during the […] - 2025-04-29 05:22:55
UBS Group Issues Pessimistic Forecast for Harmony Biosciences (NASDAQ:HRMY) Stock Price: Harmony Biosciences (NASDAQ:HRMY – Free Report) had its price target lowered by UBS Group from $55.00 to $48.00 in a research note released on Monday, MarketBeat.com reports. UBS Group currently has a buy rating on the stock. A number of other equities analysts have also commented on the stock. Deutsche Bank Aktiengesellschaft initiated coverage on […] - 2025-04-29 04:28:55
Envestnet Asset Management Inc. Raises Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY): Envestnet Asset Management Inc. raised its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Free Report) by 2.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 53,826 shares of the company’s stock after buying an additional 1,321 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Harmony Biosciences were worth $1,852,000 at […] - 2025-04-28 04:37:03

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc HRMY holdings

Date	Number of HRMY Shares Held	Base Market Value of HRMY Shares	Local Market Value of HRMY Shares	Change in HRMY Shares Held	Change in HRMY Base Value	Current Price per HRMY Share Held	Previous Price per HRMY Share Held
2025-09-26 (Friday)	4,413	USD 121,402	USD 121,402
2025-09-25 (Thursday)	4,413	USD 119,328	USD 119,328	0	USD 1,236	USD 27.0401	USD 26.76
2025-09-24 (Wednesday)	4,413	USD 118,092	USD 118,092
2025-09-17 (Wednesday)	4,385	USD 140,583	USD 140,583	0	USD -1,009	USD 32.06	USD 32.2901
2025-09-16 (Tuesday)	4,385	USD 141,592	USD 141,592
2025-09-12 (Friday)	4,357	USD 141,123	USD 141,123
2025-09-11 (Thursday)	4,357	USD 145,611	USD 145,611	56	USD -8,494	USD 33.42	USD 35.83

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of HRMY by Blackrock for IE00B3VWM098

Show aggregate share trades of HRMY

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-11 BUY 56 33.420* 33.98
2025-08-21 SELL -14 37.290* 33.96 Profit of 475 on sale
2025-07-31 BUY 42 35.180* 33.94
2025-06-30 SELL -28 31.600* 33.89 Profit of 949 on sale
2025-06-25 SELL -14 31.570* 33.93 Profit of 475 on sale
2025-06-20 SELL -28 31.890* 33.97 Profit of 951 on sale
2025-05-23 BUY 14 34.170* 33.94
2025-05-19 SELL -14 35.910* 33.90 Profit of 475 on sale
2025-05-15 SELL -42 34.230* 33.89 Profit of 1,423 on sale
2025-05-12 SELL -14 35.650* 33.87 Profit of 474 on sale
2025-05-09 SELL -14 34.050* 33.87 Profit of 474 on sale
2025-04-30 SELL -14 29.470* 34.04 Profit of 477 on sale
2025-04-24 SELL -28 29.430* 34.22 Profit of 958 on sale
2025-04-17 SELL -14 28.460* 34.51 Profit of 483 on sale
2025-04-15 SELL -42 28.750* 34.65 Profit of 1,455 on sale
2025-04-14 SELL -42 29.530* 34.70 Profit of 1,458 on sale
2025-04-09 SELL -56 29.070* 34.89 Profit of 1,954 on sale
2025-04-07 SELL -98 28.400* 35.04 Profit of 3,434 on sale
2025-04-04 SELL -140 29.260* 35.11 Profit of 4,916 on sale
2025-03-31 BUY 14 33.190* 35.20
2025-03-19 SELL -28 34.400* 35.33 Profit of 989 on sale
2025-03-14 SELL -84 32.720* 35.39 Profit of 2,973 on sale
2025-03-13 SELL -28 32.720* 35.43 Profit of 992 on sale
2025-03-12 SELL -476 33.600* 35.45 Profit of 16,876 on sale
2025-03-07 SELL -28 33.670* 35.52 Profit of 995 on sale
2025-03-06 SELL -42 33.710* 35.55 Profit of 1,493 on sale
2025-03-03 SELL -14 32.180* 35.68 Profit of 500 on sale
2025-02-28 SELL -84 33.850* 35.71 Profit of 3,000 on sale
2025-02-26 SELL -14 33.470* 35.80 Profit of 501 on sale
2025-02-25 SELL -42 36.970* 35.78 Profit of 1,503 on sale
2025-02-18 BUY 70 39.090* 35.80
2025-02-13 BUY 14 39.075* 35.61
2025-02-12 BUY 14 37.840* 35.56
2025-02-11 BUY 42 37.740* 35.52
2025-02-06 BUY 126 38.780* 35.35
2025-01-27 BUY 14 38.250* 34.59
2024-12-30 BUY 70 34.060* 34.39
2024-12-06 BUY 56 33.760* 34.50
2024-12-05 BUY 14 33.490* 34.53
2024-12-04 BUY 70 34.920* 34.52
2024-11-29 BUY 70 34.670* 34.49
2024-11-27 BUY 56 35.750* 34.38
2024-11-26 BUY 14 34.830* 34.36
2024-11-21 BUY 70 33.230* 34.41
2024-11-20 BUY 42 32.790* 34.50
2024-11-18 BUY 168 33.070* 34.72
2024-11-12 BUY 112 35.080* 34.69
2024-11-08 BUY 70 36.080* 34.59
2024-11-07 BUY 210 34.910* 34.57
2024-11-06 BUY 28 34.290* 34.59
2024-10-31 BUY 14 32.130* 35.43
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-11	BUY	56	33.420*	33.98
2025-08-21	SELL	-14	37.290*	33.96 Profit of 475 on sale
2025-07-31	BUY	42	35.180*	33.94
2025-06-30	SELL	-28	31.600*	33.89 Profit of 949 on sale
2025-06-25	SELL	-14	31.570*	33.93 Profit of 475 on sale
2025-06-20	SELL	-28	31.890*	33.97 Profit of 951 on sale
2025-05-23	BUY	14	34.170*	33.94
2025-05-19	SELL	-14	35.910*	33.90 Profit of 475 on sale
2025-05-15	SELL	-42	34.230*	33.89 Profit of 1,423 on sale
2025-05-12	SELL	-14	35.650*	33.87 Profit of 474 on sale
2025-05-09	SELL	-14	34.050*	33.87 Profit of 474 on sale
2025-04-30	SELL	-14	29.470*	34.04 Profit of 477 on sale
2025-04-24	SELL	-28	29.430*	34.22 Profit of 958 on sale
2025-04-17	SELL	-14	28.460*	34.51 Profit of 483 on sale
2025-04-15	SELL	-42	28.750*	34.65 Profit of 1,455 on sale
2025-04-14	SELL	-42	29.530*	34.70 Profit of 1,458 on sale
2025-04-09	SELL	-56	29.070*	34.89 Profit of 1,954 on sale
2025-04-07	SELL	-98	28.400*	35.04 Profit of 3,434 on sale
2025-04-04	SELL	-140	29.260*	35.11 Profit of 4,916 on sale
2025-03-31	BUY	14	33.190*	35.20
2025-03-19	SELL	-28	34.400*	35.33 Profit of 989 on sale
2025-03-14	SELL	-84	32.720*	35.39 Profit of 2,973 on sale
2025-03-13	SELL	-28	32.720*	35.43 Profit of 992 on sale
2025-03-12	SELL	-476	33.600*	35.45 Profit of 16,876 on sale
2025-03-07	SELL	-28	33.670*	35.52 Profit of 995 on sale
2025-03-06	SELL	-42	33.710*	35.55 Profit of 1,493 on sale
2025-03-03	SELL	-14	32.180*	35.68 Profit of 500 on sale
2025-02-28	SELL	-84	33.850*	35.71 Profit of 3,000 on sale
2025-02-26	SELL	-14	33.470*	35.80 Profit of 501 on sale
2025-02-25	SELL	-42	36.970*	35.78 Profit of 1,503 on sale
2025-02-18	BUY	70	39.090*	35.80
2025-02-13	BUY	14	39.075*	35.61
2025-02-12	BUY	14	37.840*	35.56
2025-02-11	BUY	42	37.740*	35.52
2025-02-06	BUY	126	38.780*	35.35
2025-01-27	BUY	14	38.250*	34.59
2024-12-30	BUY	70	34.060*	34.39
2024-12-06	BUY	56	33.760*	34.50
2024-12-05	BUY	14	33.490*	34.53
2024-12-04	BUY	70	34.920*	34.52
2024-11-29	BUY	70	34.670*	34.49
2024-11-27	BUY	56	35.750*	34.38
2024-11-26	BUY	14	34.830*	34.36
2024-11-21	BUY	70	33.230*	34.41
2024-11-20	BUY	42	32.790*	34.50
2024-11-18	BUY	168	33.070*	34.72
2024-11-12	BUY	112	35.080*	34.69
2024-11-08	BUY	70	36.080*	34.59
2024-11-07	BUY	210	34.910*	34.57
2024-11-06	BUY	28	34.290*	34.59
2024-10-31	BUY	14	32.130*	35.43

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of HRMY

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	108,472	5,348	234,711	46.2%
2025-09-18	111,025	8,894	325,984	34.1%
2025-09-17	95,108	100	187,883	50.6%
2025-09-16	128,097	12,358	317,226	40.4%
2025-09-15	135,209	0	300,082	45.1%
2025-09-12	151,923	2,495	255,315	59.5%
2025-09-11	161,565	9,535	281,361	57.4%
2025-09-10	113,595	3,149	207,043	54.9%
2025-09-09	206,183	22,917	461,817	44.6%
2025-09-08	186,749	62,734	443,997	42.1%
2025-09-05	84,992	23,242	293,945	28.9%
2025-09-04	133,575	21,855	288,006	46.4%
2025-09-03	241,435	124,278	394,903	61.1%
2025-09-02	137,281	52,607	257,771	53.3%
2025-08-29	96,248	39,096	140,248	68.6%
2025-08-28	97,910	0	133,987	73.1%
2025-08-27	104,114	500	187,482	55.5%
2025-08-26	57,186	0	93,881	60.9%
2025-08-25	84,400	0	146,263	57.7%
2025-08-22	47,530	0	213,949	22.2%
2025-08-21	84,102	2,300	140,928	59.7%
2025-08-20	98,690	0	183,563	53.8%
2025-08-19	80,039	0	168,820	47.4%
2025-08-18	83,964	303	156,507	53.6%
2025-08-15	69,487	8	121,076	57.4%
2025-08-14	71,337	844	119,721	59.6%
2025-08-13	80,927	26	168,515	48.0%
2025-08-12	76,331	23	129,342	59.0%
2025-08-11	98,526	506	189,091	52.1%
2025-08-08	75,529	0	129,887	58.1%
2025-08-07	80,052	0	140,751	56.9%
2025-08-06	98,350	6,300	192,173	51.2%
2025-08-05	267,646	547	468,852	57.1%
2025-08-04	151,988	0	230,053	66.1%
2025-08-01	111,295	34	186,988	59.5%
2025-07-31	75,187	0	140,326	53.6%
2025-07-30	92,085	0	197,551	46.6%
2025-07-29	103,043	38	188,117	54.8%
2025-07-28	122,300	0	234,869	52.1%
2025-07-25	111,075	0	232,332	47.8%
2025-07-24	76,583	0	125,414	61.1%
2025-07-23	107,722	19	215,186	50.1%
2025-07-22	258,651	1,287	348,816	74.2%
2025-07-21	210,151	0	270,413	77.7%
2025-07-18	133,326	960	251,003	53.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE